Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
EMERAMED LTD
Jurisdiction of Incorporation/Organization
IRELAND
Year of Incorporation/Organization
2014
Item 2 Issuer Principal Place of Business and Contact Information
7/8 WILTON TERRACE
DUBLIN, L2 2
Phone Number:
subscription required
Item 3. Related Persons
Name
BOYD E HALEY
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
- PROMOTER
Clarification of Response
Item 3. Related Persons
Name
RAGNAR KLINGBERG
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
J TODD RENNER
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
KATHRYN M WACHSMAN
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
11/02/2016
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
Yes
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
1000
Item 13. Offering and Sales Amounts
Total Offering Amount
INDEFINITE
Total Amount Sold
274217
Total Remaining to be Sold
INDEFINITE
Clarification of Response
AMOUNTS SOLD REFLECT ALL SALES MADE IN RELIANCE UPON EXEMPTION CLAIMED IN THIS FORM D. ALL INVESTMENTS IN EUROS HAVE BEEN CONVERTED TO US DOLLARS AS OF THE TRANSACTION DATE.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
6
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
EMERAMED LTD
Issuer Signature
J. TODD RENNER
Signer Name
J. TODD RENNER
Signer Title
CHIEF FINANCIAL OFFICER
Signature Date
11/15/2016